JEFF EVANS
Impact in
- Pharmacology top 10%
- Inflammatory mediators and NSAID effects
- Toxicology top 10%
Papers in
- Co-authors
- Thomas M. MacDonald (5 shared papers)Alex D. McMahon (1 shared paper)Frank E. Murray (1 shared paper)DG McDevitt (1 shared paper)S. Ogston (1 shared paper)Andrew D. Morris (1 shared paper)Karen Barnett (1 shared paper)Marie‐Christine Jones (1 shared paper)
- Journals
- Journal of Cystic Fibrosis (2 papers)Blood (1 paper)British Journal of Anaesthesia (1 paper)Gut (1 paper)Psychotherapy and Psychosomatics (1 paper)
- Partner nations
- United KingdomSingaporeUnited States
In The Last Decade
JEFF EVANS
18 papers receiving 369 citations
Peers
Comparison fields: 5 of 86
- Pharmacology 117
- Toxicology 20
- Gastroenterology 21
- Epidemiology 132
- Genetics 97
Countries citing papers authored by JEFF EVANS
This map shows the geographic impact of JEFF EVANS's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JEFF EVANS with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JEFF EVANS more than expected).
Fields of papers citing papers by JEFF EVANS
This network shows the impact of papers produced by JEFF EVANS. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JEFF EVANS. The network helps show where JEFF EVANS may publish in the future.
Co-authors
The 25 scholars most cited alongside JEFF EVANS, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 168 | |
| 2 | 1995 | 80 | |
| 3 | 2007 | 48 | |
| 4 | 2000 | 24 | |
| 5 | 1997 | 23 | |
| 6 | 2002 | 10 | |
| 7 | Potentially hazardous co-prescribing of beta-adrenoceptor antagonists and agonists in the community. | 1996 | 8 |
| 8 | 2018 | 4 | |
| 9 | 1969 | 4 | |
| 10 | 2023 | 3 | |
| 11 | Doppler spectral broadening and anomalous vessel wall movement in the study of atherosclerosis of the carotid arteries. | 1983 | 3 |
| 12 | 2006 | 2 | |
| 13 | 1965 | 2 | |
| 14 | The discovery of Aotearoa | 1998 | 2 |
| 15 | Maori Weapons in Pre-European New Zealand | 2002 | 2 |
| 16 | 2008 | 1 | |
| 17 | 2002 | 1 | |
| 18 | 2007 | 1 | |
| 19 | 2018 | 0 | |
| 20 | 2010 | 0 |
About JEFF EVANS
JEFF EVANS is a scholar working on Epidemiology, Clinical Psychology, Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health and Oncology, having authored 22 papers that have together received 386 indexed citations. Recurring topics across this work include CAR-T cell therapy research (2 papers), Pediatric health and respiratory diseases (2 papers), Pacific and Southeast Asian Studies (2 papers), Pharmacovigilance and Adverse Drug Reactions (1 paper), Pharmaceutical Practices and Patient Outcomes (1 paper), Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper), Health Literacy and Information Accessibility (1 paper) and Health Promotion and Cardiovascular Prevention (1 paper). The work is most often cited by research in Pharmacology (117 citations), Toxicology (20 citations), Gastroenterology (21 citations), Epidemiology (132 citations) and Genetics (97 citations). JEFF EVANS has collaborated with scholars based in United Kingdom, Singapore and United States. Frequent co-authors include Thomas M. MacDonald, Alex D. McMahon, Frank E. Murray, DG McDevitt, S. Ogston, Andrew D. Morris, Karen Barnett, Marie‐Christine Jones, Mark McGilchrist and G. White. Their work appears in journals such as Journal of Cystic Fibrosis, Blood, British Journal of Anaesthesia, Gut and Psychotherapy and Psychosomatics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.